title: The calm before the storm: a report from the International Liver Cancer Association Congress 2015--part 1.
abstract: International Liver Cancer Association Congress 2015, Paris, France, 4-6 September 2015 Since its creation 9 years ago, in 2007, the International Liver Cancer Association has focused on the multidisciplinary approach to liver cancer due to advances in hepatology science and care worldwide. In its 2015 annual conference, held on 4-6 September in Paris, France, the most recent progresses in the basic biology, management and treatment of liver cancer have been presented. This report, divided into two parts, introduces and critically reviews some of the most intriguing topics discussed at the meeting.
authors.affiliation: Section of Gastroenterology, Di.Bi.M.I.S., University of Palermo, 90133 Palermo, Italy.
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Cabibbo
authors.affiliation: Barcelona Clinic Liver Cancer (BCLC) Group, Liver Unit, Hospital Clínic Barcelona, IDIBAPS, University of Barcelona, 08007 Barcelona, Spain.|Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Barcelona, Spain.
authors.forename: Maria
authors.initials: M
authors.lastname: Reig
authors.affiliation: Division of Oncology, 'Mons R. Dimiccioli' Hospital, Barletta (BT), ASL BAT, Italy.
authors.forename: Gennaro
authors.initials: G
authors.lastname: Gadaleta-Caldarola
authors.affiliation: Unit of Internal Medicine & Hepatology, Department of Medicine, Università Campus Bio-Medico di Roma, via Álvaro del Portillo 21, 00128 Rome, Italy.
authors.forename: Giovanni
authors.initials: G
authors.lastname: Galati
authors.affiliation: Department of Clinical & Experimental Oncology, Medical Oncology 1, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy.
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Lombardi
authors.affiliation: Department of Radiology, Spedali Civili, 25123 Brescia BS, Italy.
authors.forename: GianCarlo
authors.initials: G
authors.lastname: Mazza
authors.affiliation: Gastroenterology Unit, Policlinico di Modena, 41124 Modena MO, Italy.
authors.forename: Luca
authors.initials: L
authors.lastname: Marzi
authors.affiliation: Division of Clinical & Molecular Hepatology, Department of Internal Medicine, University Hospital of Messina, Messina, Italy.
authors.forename: Carlo
authors.initials: C
authors.lastname: Saitta
authors.affiliation: Liver unit, Hôpital Jean Verdier, Hôpitaux Universitaires Paris-Seine-Saint-Denis, Assistance-Publique Hôpitaux de Paris, 93140 Bondy, France.|Unité Mixte de Recherche 1162, Génomique Fonctionnelle des Tumeurs Solides, Institut National de la Santé et de la Recherche Médicale, Paris, France.|Unité de Formation et de Recherche Santé Médecine et Biologie Humaine, Université Paris 13, Communauté d'Universités et Etablissements Sorbonne Paris Cité, Paris, France.
authors.forename: Jean-Charles
authors.initials: JC
authors.lastname: Nault
authors.affiliation: Dipartimento di Gastroenterologia-UO Gastroenterologia e Malattie del Ricambio, Azienda Ospedaliero Universitaria Pisana, Ospedale Cisanello, 56126 Pisa PI, Italy.
authors.forename: Rodolfo
authors.initials: R
authors.lastname: Sacco
mesh_terms: D006528:Carcinoma, Hepatocellular / Q000628:therapy*; D019468:Disease Management; D006801:Humans; D008113:Liver Neoplasms / Q000628:therapy*
keywords: HCC; immunotherapy; liver cancer; prognosis; sorafenib; staging system; survival; trial design